Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Aug 1, 2017
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-07-31$7.14/sh−1,445$10,317→ 142,282 total
Footnotes (2)
- [F1]Sale of a total of 1,445 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on July 28, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 90,621 shares of restricted stock.